Clinical trials
Withdrawn Triple Negative Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 8 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 52 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| City of Hope Medical Center | 2 |
| ImmunityBio, Inc. | 2 |
| M.D. Anderson Cancer Center | 2 |
| University of Southern California | 2 |
| Washington University School of Medicine | 2 |
| AHS Cancer Control Alberta | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Cedars-Sinai Medical Center | 1 |
| Dana-Farber Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 52 |
| Breast Neoplasms | 23 |
| Ovarian Neoplasms | 8 |
| Neoplasm Metastasis | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Colorectal Neoplasms | 3 |
| Endometrial Neoplasms | 3 |
| Inflammatory Breast Neoplasms | 3 |
| Neoplasms | 3 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
Trials
Showing 51 to 52 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.